Medicare and Medicaid Programs; Announcement of an Application From a Hospital Requesting Waiver for Organ Procurement Service Area, 35141-35142 [E8-13821]
Download as PDF
Federal Register / Vol. 73, No. 120 / Friday, June 20, 2008 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1812–NC]
Medicare and Medicaid Programs;
Announcement of an Application From
a Hospital Requesting Waiver for
Organ Procurement Service Area
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice with comment period.
jlentini on PROD1PC65 with NOTICES
AGENCY:
SUMMARY: This notice announces a
hospital’s request for a waiver from
entering into an agreement with its
designated organ procurement
organization (OPO).
This notice requests comments from
OPOs and the general public for our
consideration in determining whether
we should grant the requested waiver.
DATE: Comment Date: To be assured
consideration, comments must be
received at one of the addresses
provided below, no later than 5 p.m. on
August 19, 2008.
ADDRESSES: In commenting, please refer
to file code CMS–1812-NC. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
You may submit comments in one of
four ways (please choose only one of the
ways listed):
1. Electronically. You may submit
electronic comments on specific issues
in this regulation to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ and enter the filecode to
find the document accepting comments.
2. By regular mail. You may mail
written comments (one original and two
copies) to the following address ONLY:
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, Attention: CMS–1812–
NC, P.O. Box 8016, Baltimore, MD
21244–8016.
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments (one
original and two copies) to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–1812–NC, Mail Stop C4–26–05,
7500 Security Boulevard, Baltimore, MD
21244–1850.
4. By hand or courier. If you prefer,
you may deliver (by hand or courier)
your written comments (one original
VerDate Aug<31>2005
16:53 Jun 19, 2008
Jkt 214001
and two copies) before the close of the
comment period to either of the
following addresses.
a. Room 445–G, Hubert H. Humphrey
Building, 200 Independence Avenue,
SW., Washington, DC 20201.
(Because access to the interior of the
HHH Building is not readily available to
persons without Federal Government
identification, commenters are
encouraged to leave their comments in
the CMS drop slots located in the main
lobby of the building. A stamp-in clock
is available for persons wishing to retain
a proof of filing by stamping in and
retaining an extra copy of the comments
being filed.)
b. 7500 Security Boulevard,
Baltimore, MD 21244–1850.
If you intend to deliver your
comments to the Baltimore address,
please call telephone number (410) 786–
9994 in advance to schedule your
arrival with one of our staff members.
Comments mailed to the addresses
indicated as appropriate for hand or
courier delivery may be delayed and
received after the comment period.
FOR FURTHER INFORMATION CONTACT:
Mark A. Horney, (410) 786–4554.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All
comments received before the close of
the comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following Web
site as soon as possible after they have
been received: https://
www.regulations.gov. Follow the search
instructions on that Web site to view
public comments.
Comments received timely will also
be available for public inspection as
they are received, generally beginning
approximately 3 weeks after publication
of a document, at the headquarters of
the Centers for Medicare & Medicaid
Services, 7500 Security Boulevard,
Baltimore, Maryland 21244, Monday
through Friday of each week from 8:30
a.m. to 4 p.m. To schedule an
appointment to view public comments,
phone 1–800–743–3951.
I. Background
Organ Procurement Organizations
(OPOs) are not-for-profit organizations
that are responsible for the
procurement, preservation, and
transport of transplantable organs to
transplant centers throughout the
country. OPOs are certified by the
Centers for Medicare & Medicaid
Services (CMS) to recover or procure
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
35141
organs in CMS-defined exclusive
designated service areas (DSAs),
according to section 371(b)(1)(F) of the
Public Health Service Act (42 U.S.C.
273(b)(1)(F)) and our regulations at 42
CFR 486.303 through 486.308. Once an
OPO has been designated for a DSA,
hospitals and critical access hospitals
(CAHs) in that DSA that participate in
Medicare and Medicaid are required to
work with that OPO in procuring organs
for transplant, according to section
1138(a)(1)(C) of the Social Security Act
(the Act), and our regulations at
§ 482.45.
Section 1138(a)(1)(A)(iii) of the Act
provides that a hospital or CAH must
notify the designated OPO (for the DSA
in which it is located) of potential organ
donors. Under section 1138(a)(1)(C) of
the Act, every participating hospital
must have an agreement to identify
potential donors only with its
designated OPO.
However, section 1138(a)(2)(A) of the
Act provides that a hospital or CAH may
obtain from the Secretary a waiver of the
above requirements under certain
specified conditions. A waiver allows
the hospital to have an agreement with
an OPO other than the one designated
by CMS for the DSA in which the
hospital or CAH is located, if the
hospital meets certain conditions
specified in section 1138(a)(2)(A) of the
Act. In addition, the Secretary may
review additional criteria described in
section 1138(a)(2)(B) of the Act to
evaluate the hospital’s request for a
waiver.
Section 1138(a)(2)(A) of the Act states
that in granting a waiver, the Secretary
must determine that the waiver—(1) is
expected to increase organ donations;
and (2) will ensure equitable treatment
of patients referred for transplants
within the service area served by the
designated OPO and within the service
area served by the OPO with which the
hospital seeks to enter into an
agreement under the waiver. In making
a waiver determination, section
1138(a)(2)(B) of the Act provides that
the Secretary may consider, among
other factors: (1) Cost-effectiveness; (2)
improvements in quality; (3) whether
there has been any change in a
hospital’s designated OPO due to the
changes made in definitions for
metropolitan statistical areas; and (4)
the length and continuity of a hospital’s
relationship with an OPO other than the
hospital’s designated OPO. Under
section 1138(a)(2)(D) of the Act, the
Secretary is required to publish a notice
of any waiver application received from
a hospital within 30 days of receiving
the application, and before making a
final determination on the waiver
E:\FR\FM\20JNN1.SGM
20JNN1
35142
Federal Register / Vol. 73, No. 120 / Friday, June 20, 2008 / Notices
applicability offer interested parties an
opportunity to comment in writing
during the 60-day period beginning on
the date the notice is published in the
Federal Register.
The criteria that the Secretary uses to
evaluate the waiver in these cases are
the same as those described above under
sections 1138(a)(2)(A) and (B) of the Act
and have been incorporated into the
regulations at § 486.308(e) and (f).
II. Waiver Request Procedures
In October 1995, we issued a Program
Memorandum (Transmittal No. A–95–
11) detailing the waiver process and
discussing the information that
hospitals must provide in requesting a
waiver. We indicated that upon receipt
of a waiver request, we would publish
a Federal Register notice to solicit
public comments, as required by section
1138(a)(2)(D) of the Act.
According to these requirements, we
will review the request and comments
received. During the review process, we
may consult on an as-needed basis with
the Public Health Service’s Division of
Transplantation, the United Network for
Organ Sharing, and our regional offices.
If necessary, we may request additional
clarifying information from the applying
hospital or others. We will then make a
final determination on the waiver
request and notify the hospital and the
designated and requested OPOs.
III. Hospital Waiver Request
As permitted by § 486.308(e),
McCullough-Hyde Memorial Hospital of
Oxford, Ohio has requested a waiver in
order to enter into an agreement with a
designated OPO other than the OPO
designated for the DSA in which the
hospital is located. McCullough-Hyde
Memorial Hospital is requesting a
waiver to work with: LifeConnection of
Ohio, 40 Wyoming Street, Dayton, OH
45409.
McCullough-Hyde Memorial Hospital’s
Designated OPO is: LifeCenter Organ
Donor Network, 2925 Vernon Place,
Suite 300, Cincinnati, OH 45219.
jlentini on PROD1PC65 with NOTICES
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; Program No. 93.774, Medicare—
Supplementary Medical Insurance, and
Program No. 93.778, Medical Assistance
Program)
Dated: June 9, 2008.
Kerry Weems,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. E8–13821 Filed 6–19–08; 8:45 am]
BILLING CODE 4120–01–P
VerDate Aug<31>2005
16:53 Jun 19, 2008
Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Notice of Public Comment on Tribal
Consultation Sessions To Be Held on
July 21, July 23, and July 31, 2008
Office of Head Start (OHS),
Administration for Children and
Families, HHS.
ACTION: Notice of Public Comment on
Tribal Consultation Sessions to be held
on July 21, July 23, and July 31, 2008.
AGENCY:
SUMMARY: Pursuant to the Improving
Head Start for School Readiness Act of
2007, Public Law 110–134, notice is
hereby given of three one-day Tribal
Consultation Sessions to be held
between the Department of Health and
Human Services, Administration for
Children and Families, Office of Head
Start leadership and the leadership of
Tribal governments operating Head Start
(including Early Head Start) programs.
The purpose of these Consultation
Sessions is to discuss ways to better
meet the needs of Indian, including
Alaska Native, children and their
families, taking into consideration
funding allocations, distribution
formulas, and other issues affecting the
delivery of Head Start services in their
geographic locations [42.U.S.C. 9835,
Section 640(l)(4)].
Dates & Locations:
July 21, 2008—Kansas City, Missouri.
July 23, 2008—Denver, Colorado.
July 31, 2008—Seattle, Washington.
FOR FURTHER INFORMATION CONTACT:
´
Renee Perthuis, Acting Regional
Program Manager, American Indian/
Alaska Native Program Branch, Office of
Head Start, e-mail
reneeaian@acf.hhs.gov or (202) 260–
1721. Register to attend one of these
sessions online at https://www.hsnrc.org.
SUPPLEMENTARY INFORMATION: The
Department of Health and Human
Services would like to invite leaders of
Tribal governments operating Head Start
(including Early Head Start) programs to
participate in a formal Consultation
Session with OHS leadership. The
Consultation Sessions will take place as
follows:
July 21, 2008—Kansas City, Missouri.
July 23, 2008—Denver, Colorado.
July 31, 2008—Seattle, Washington.
Limited resources (fiscal, staff, and
time constraints) preclude holding a
Consultation Session in each ACF
Region. These three Regions (VII, VIII,
and X) have been selected in an attempt
to accommodate the majority of Tribes
operating Head Start and Early Head
Start programs.
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
The purpose of the Consultation
Sessions is to solicit input on ways to
better meet the needs of Indian,
including Alaska Native, children and
their families, taking into consideration
funding allocations, distribution
formulas, and other issues affecting the
delivery of Head Start services in their
geographic locations. Specific topics
will include policy, research, Head
Start/Early Head Start conversion,
program quality, and monitoring.
Tribal leaders and designated
representatives interested in submitting
written testimony or topics for the
Consultation Session agenda should
´
contact Renee Perthuis at
reneeaian@acf.hhs.gov. Tribal leaders
submitting testimony or topics should
provide a brief description of the subject
matter along with contact information
for the proposed presenter.
The Consultation Sessions will be
conducted with elected or appointed
leaders of Tribal governments and their
designated representatives [42.U.S.C.
9835, Section 640(l)(4)(A)].
Representatives from Tribal
organizations and Native non-profit
organizations are welcome to attend as
observers. Those wishing to participate
in the discussions must have a copy of
a written resolution, voted on and
approved by the Tribal government,
which authorizes them to serve as a
representative of the Tribe. This should
be submitted not less than three days in
advance of the Consultation Session to
´
Renee Perthuis at 202–260–9336 (fax).
A detailed report of each Consultation
Session will be prepared and made
available within 90 days of each
consultation to all Tribal governments
receiving funds for Head Start
(including Early Head Start) programs.
Dated: June 16, 2008.
Patricia Brown,
Acting Director, Office of Head Start.
[FR Doc. E8–14015 Filed 6–19–08; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–1986–F–0277] (formerly
Docket No. 1986F–0364)
Danisco USA, Inc.; Withdrawal of Food
Additive Petition
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
withdrawal, without prejudice to a
E:\FR\FM\20JNN1.SGM
20JNN1
Agencies
[Federal Register Volume 73, Number 120 (Friday, June 20, 2008)]
[Notices]
[Pages 35141-35142]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-13821]
[[Page 35141]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-1812-NC]
Medicare and Medicaid Programs; Announcement of an Application
From a Hospital Requesting Waiver for Organ Procurement Service Area
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: This notice announces a hospital's request for a waiver from
entering into an agreement with its designated organ procurement
organization (OPO).
This notice requests comments from OPOs and the general public for
our consideration in determining whether we should grant the requested
waiver.
DATE: Comment Date: To be assured consideration, comments must be
received at one of the addresses provided below, no later than 5 p.m.
on August 19, 2008.
ADDRESSES: In commenting, please refer to file code CMS-1812-NC.
Because of staff and resource limitations, we cannot accept comments by
facsimile (FAX) transmission.
You may submit comments in one of four ways (please choose only one
of the ways listed):
1. Electronically. You may submit electronic comments on specific
issues in this regulation to https://www.regulations.gov. Follow the
instructions for ``Comment or Submission'' and enter the filecode to
find the document accepting comments.
2. By regular mail. You may mail written comments (one original and
two copies) to the following address ONLY: Centers for Medicare &
Medicaid Services, Department of Health and Human Services, Attention:
CMS-1812-NC, P.O. Box 8016, Baltimore, MD 21244-8016.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments (one
original and two copies) to the following address ONLY: Centers for
Medicare & Medicaid Services, Department of Health and Human Services,
Attention: CMS-1812-NC, Mail Stop C4-26-05, 7500 Security Boulevard,
Baltimore, MD 21244-1850.
4. By hand or courier. If you prefer, you may deliver (by hand or
courier) your written comments (one original and two copies) before the
close of the comment period to either of the following addresses.
a. Room 445-G, Hubert H. Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201.
(Because access to the interior of the HHH Building is not readily
available to persons without Federal Government identification,
commenters are encouraged to leave their comments in the CMS drop slots
located in the main lobby of the building. A stamp-in clock is
available for persons wishing to retain a proof of filing by stamping
in and retaining an extra copy of the comments being filed.)
b. 7500 Security Boulevard, Baltimore, MD 21244-1850.
If you intend to deliver your comments to the Baltimore address,
please call telephone number (410) 786-9994 in advance to schedule your
arrival with one of our staff members.
Comments mailed to the addresses indicated as appropriate for hand
or courier delivery may be delayed and received after the comment
period.
FOR FURTHER INFORMATION CONTACT: Mark A. Horney, (410) 786-4554.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All comments received before the
close of the comment period are available for viewing by the public,
including any personally identifiable or confidential business
information that is included in a comment. We post all comments
received before the close of the comment period on the following Web
site as soon as possible after they have been received: https://
www.regulations.gov. Follow the search instructions on that Web site to
view public comments.
Comments received timely will also be available for public
inspection as they are received, generally beginning approximately 3
weeks after publication of a document, at the headquarters of the
Centers for Medicare & Medicaid Services, 7500 Security Boulevard,
Baltimore, Maryland 21244, Monday through Friday of each week from 8:30
a.m. to 4 p.m. To schedule an appointment to view public comments,
phone 1-800-743-3951.
I. Background
Organ Procurement Organizations (OPOs) are not-for-profit
organizations that are responsible for the procurement, preservation,
and transport of transplantable organs to transplant centers throughout
the country. OPOs are certified by the Centers for Medicare & Medicaid
Services (CMS) to recover or procure organs in CMS-defined exclusive
designated service areas (DSAs), according to section 371(b)(1)(F) of
the Public Health Service Act (42 U.S.C. 273(b)(1)(F)) and our
regulations at 42 CFR 486.303 through 486.308. Once an OPO has been
designated for a DSA, hospitals and critical access hospitals (CAHs) in
that DSA that participate in Medicare and Medicaid are required to work
with that OPO in procuring organs for transplant, according to section
1138(a)(1)(C) of the Social Security Act (the Act), and our regulations
at Sec. 482.45.
Section 1138(a)(1)(A)(iii) of the Act provides that a hospital or
CAH must notify the designated OPO (for the DSA in which it is located)
of potential organ donors. Under section 1138(a)(1)(C) of the Act,
every participating hospital must have an agreement to identify
potential donors only with its designated OPO.
However, section 1138(a)(2)(A) of the Act provides that a hospital
or CAH may obtain from the Secretary a waiver of the above requirements
under certain specified conditions. A waiver allows the hospital to
have an agreement with an OPO other than the one designated by CMS for
the DSA in which the hospital or CAH is located, if the hospital meets
certain conditions specified in section 1138(a)(2)(A) of the Act. In
addition, the Secretary may review additional criteria described in
section 1138(a)(2)(B) of the Act to evaluate the hospital's request for
a waiver.
Section 1138(a)(2)(A) of the Act states that in granting a waiver,
the Secretary must determine that the waiver--(1) is expected to
increase organ donations; and (2) will ensure equitable treatment of
patients referred for transplants within the service area served by the
designated OPO and within the service area served by the OPO with which
the hospital seeks to enter into an agreement under the waiver. In
making a waiver determination, section 1138(a)(2)(B) of the Act
provides that the Secretary may consider, among other factors: (1)
Cost-effectiveness; (2) improvements in quality; (3) whether there has
been any change in a hospital's designated OPO due to the changes made
in definitions for metropolitan statistical areas; and (4) the length
and continuity of a hospital's relationship with an OPO other than the
hospital's designated OPO. Under section 1138(a)(2)(D) of the Act, the
Secretary is required to publish a notice of any waiver application
received from a hospital within 30 days of receiving the application,
and before making a final determination on the waiver
[[Page 35142]]
applicability offer interested parties an opportunity to comment in
writing during the 60-day period beginning on the date the notice is
published in the Federal Register.
The criteria that the Secretary uses to evaluate the waiver in
these cases are the same as those described above under sections
1138(a)(2)(A) and (B) of the Act and have been incorporated into the
regulations at Sec. 486.308(e) and (f).
II. Waiver Request Procedures
In October 1995, we issued a Program Memorandum (Transmittal No. A-
95-11) detailing the waiver process and discussing the information that
hospitals must provide in requesting a waiver. We indicated that upon
receipt of a waiver request, we would publish a Federal Register notice
to solicit public comments, as required by section 1138(a)(2)(D) of the
Act.
According to these requirements, we will review the request and
comments received. During the review process, we may consult on an as-
needed basis with the Public Health Service's Division of
Transplantation, the United Network for Organ Sharing, and our regional
offices. If necessary, we may request additional clarifying information
from the applying hospital or others. We will then make a final
determination on the waiver request and notify the hospital and the
designated and requested OPOs.
III. Hospital Waiver Request
As permitted by Sec. 486.308(e), McCullough-Hyde Memorial Hospital
of Oxford, Ohio has requested a waiver in order to enter into an
agreement with a designated OPO other than the OPO designated for the
DSA in which the hospital is located. McCullough-Hyde Memorial Hospital
is requesting a waiver to work with: LifeConnection of Ohio, 40 Wyoming
Street, Dayton, OH 45409.
McCullough-Hyde Memorial Hospital's Designated OPO is: LifeCenter Organ
Donor Network, 2925 Vernon Place, Suite 300, Cincinnati, OH 45219.
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; Program No. 93.774, Medicare--
Supplementary Medical Insurance, and Program No. 93.778, Medical
Assistance Program)
Dated: June 9, 2008.
Kerry Weems,
Acting Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. E8-13821 Filed 6-19-08; 8:45 am]
BILLING CODE 4120-01-P